Lingnan Li
Impact in
- Rheumatology top 5%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Immunology top 10%
- Psoriasis: Treatment and Pathogenesis
Papers in
-
- Natural product bioactivities and synthesis 5
- Ginseng Biological Effects and Applications 2
-
- Psoriasis: Treatment and Pathogenesis 6
- Co-authors
- Sreekumar Pillai (5 shared papers)Peter Nash (5 shared papers)Josef S Smolen (5 shared papers)Soyi Liu Leage (3 shared papers)Philip J. Mease (4 shared papers)Hasan Tahir (4 shared papers)Eswar Krishnan (2 shared papers)Philip Helliwell (2 shared papers)
- Journals
- Annals of the Rheumatic Diseases (3 papers)Alzheimer s & Dementia (1 paper)Chemical Communications (1 paper)Food and Chemical Toxicology (1 paper)Dalton Transactions (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lingnan Li
17 papers receiving 518 citations
Peers
Comparison fields: 5 of 74
- Rheumatology 229
- Immunology 272
- Hematology 129
- Dermatology 71
- Pharmacology 42
Countries citing papers authored by Lingnan Li
This map shows the geographic impact of Lingnan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingnan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingnan Li more than expected).
Fields of papers citing papers by Lingnan Li
This network shows the impact of papers produced by Lingnan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingnan Li. The network helps show where Lingnan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingnan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 208 | |
| 2 | 2020 | 58 | |
| 3 | 2018 | 54 | |
| 4 | 2017 | 32 | |
| 5 | 2012 | 31 | |
| 6 | 2020 | 27 | |
| 7 | 2019 | 24 | |
| 8 | 2018 | 23 | |
| 9 | 2019 | 18 | |
| 10 | 2013 | 13 | |
| 11 | 2020 | 9 | |
| 12 | 2019 | 9 | |
| 13 | 2023 | 7 | |
| 14 | 2019 | 6 | |
| 15 | 2021 | 5 | |
| 16 | 2009 | 3 | |
| 17 | A Head-to-Head Comparison of Ixekizumab and Adalimumab in Biologic-Naive Patients with Active Psoriatic Arthritis: Efficacy and Safety Outcomes from a Randomized, Open-Label, Blinded Assessor Study Through 52 Weeks | 2019 | 1 |
| 18 | 2024 | 0 |
About Lingnan Li
Lingnan Li is a scholar working on Molecular Biology, Immunology, Rheumatology, Hematology and Complementary and alternative medicine, having authored 18 papers that have together received 528 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (6 papers), Natural product bioactivities and synthesis (5 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Chromatography in Natural Products (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Spondyloarthritis Studies and Treatments (3 papers), Ginseng Biological Effects and Applications (2 papers) and Traditional Chinese Medicine Analysis (2 papers). The work is most often cited by research in Rheumatology (229 citations), Immunology (272 citations), Hematology (129 citations), Dermatology (71 citations) and Pharmacology (42 citations). Lingnan Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Sreekumar Pillai, Peter Nash, Josef S Smolen, Soyi Liu Leage, Philip J. Mease, Hasan Tahir, Eswar Krishnan, Philip Helliwell, Melinda Gooderham and Frank Behrens. Their work appears in journals such as Annals of the Rheumatic Diseases, Alzheimer s & Dementia, Chemical Communications, Food and Chemical Toxicology and Dalton Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.